Share this article

How Marburg Virus Spreads

Marburg virus is transmitted to humans through contact with infected fruit bats—the reservoir host of the virus—or infected non-human primates.  

Subsequent person-to-person spread occurs through direct contact with blood or bodily fluids of an infected individual or contact with contaminated fomites or surfaces. Transmission can also occur from exposure to semen of men who have recovered from Marburg virus disease (MVD).  

Health care personnel can reduce the risk of Marburg virus disease (MVD) transmission by correctly and consistently implementing infection control measures.

Ensure Early Isolation Through the Identify, Isolate, and Inform Framework 

Use the “Identify, Isolate, and Inform” strategy to ensure individuals at risk for MVD are identified and isolated appropriately, and communication is expedited.  

  • If the patient reports possible exposure to Marburg virus AND exhibits signs or symptoms of MVD, isolate them in a private (single occupancy) room with a dedicated bathroom or a covered, bedside commode.  
  • Inform your facility’s Infection Prevention and Control Program and involved health care personnel about the suspected case; they will often support communication with local or state health departments to determine next steps, such as arranging for testing. 

In the early stages, MVD can be difficult to distinguish from other infectious diseases that might be the cause of symptoms in a returning traveler. HCP should also consider malaria, typhoid fever, dengue, or other viral hemorrhagic fevers that may be present in the area where the patient has traveled, such as Lassa fever or Ebola virus disease. 

Isolation Precautions and Personal Protective Equipment (PPE) 

The patient should be placed in a private (single occupancy) room with a private bathroom or a covered, bedside commode. The door should be kept closed. Avoid aerosol-generating procedures (AGPs), if possible. Any necessary AGPs should be performed in an airborne infection isolation room (AIIR).  

Follow the CDC’s recommendations (CDC, https://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html, Accessed 3/3/2023) for PPE, which includes PPE that fully covers skin and clothing and prevents any exposure of the eyes, nose, and mouth to reduce the risk of accidental self-contamination of mucous membranes or broken skin. 

Fully body coverage is used for patients who are “wet,” a term used to indicate patients who are diaphoretic, vomiting, bleeding, or having diarrhea. Patients who are clinically stable and do not have bleeding, vomiting, or diarrhea are considered “dry.” 

Refer to  the CDC’s Personal Protective Equipment (PPE) Training (CDC, https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/guidance/index.html, Accessed 3/3/2023) for information on the safe donning and doffing of PPE.  

Cleaning and Disinfection 

The CDC’s Cleaning and Disinfecting (CDC, https://www.cdc.gov/vhf/ebola/clinicians/cleaning/hospitals.html, Accessed 3/3/2023) guidance for Ebola virus disease also applies to MVD. Key points include: 

  • Use single-use medical equipment when available. If reusable equipment must be used, clean and disinfect it according to the Spaulding Classification scheme (CDC, https://www.cdc.gov/infectioncontrol/guidelines/disinfection/rational-approach.html, Accessed 3/3/2023). 

  • Clean and disinfect environmental surfaces at regular intervals. For disinfection, use a U.S. Environmental Protection Agency (EPA)-registered hospital disinfectant with efficacy against enveloped viruses, such as sodium hypochlorite (bleach) or quaternary ammonium. 

  • Refer to the EPA’s List L: Disinfectants for Use Against Ebola Virus (EPA, https://www.epa.gov/pesticide-registration/epas-registered-antimicrobial-products-effective-against-ebola-virus-list-l, Accessed 3/3/2023) and List Q: Disinfectants for Emerging Viral Pathogens (EVPs) (EPA, https://www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q, Accessed 3/3/2023) for additional guidance on choosing a suitable disinfectant. 

Waste Management 

Patients with MVD can produce large amounts of infectious waste. 

Marburg virus is a Category A infectious substance; NETEC’s Category A Waste Management Tips for Ebola Virus Disease provides guidance for waste management that also applies to managing waste generated by a patient with MVD. 

Other Important Infection Prevention and Control Practices 

  • Perform frequent hand hygiene  

  • Avoid entry of visitors into the patient’s room (except on a case-by-case basis when essential for the patient’s wellbeing)  

  • Limit the number of health care personnel who provide care for suspected and confirmed cases 

  • Maintain a log of all people who enter the patient’s room 
  • Develop a plan to manage HCP should they be exposed to blood or bodily fluids from a suspected or confirmed case 

  • Minimize the use of needles and other sharps  

  • When performing aerosol-generating procedures:  
    • Only essential personnel should be present. 
    • All staff should be wearing appropriate PPE, including respiratory protection, as described above. 
    • Use an airborne infection isolation room (AIIR) when AGPS are anticipated or planned. Minimize entry and exit during the procedure and shortly afterward. 

Additional Resources 

About the Authors

Justin Chan, MD, MPH, is an infectious disease physician with the NYC Health + Hospital/Bellevue Regional Emerging Special Pathogen Treatment Center (RESPTC) and serves as the System Chief Hospital Epidemiologist for NYC Health + Hospitals. He is an Assistant Professor of Medicine at NYU Grossman School of Medicine in the Division of Infectious Diseases & Immunology.

Katherine Gaddis, RN, is a public health nurse in Upstate New York and a graduate student in the University of Nebraska Medical Center (UNMC)’s online MPH-Epidemiology program. She is interested in emerging infectious diseases, infection prevention and control, and outbreak investigations. In addition to her professional interests, Katherine enjoys spending time with her family, traveling, and reading. Katherine is currently a student worker at NETEC.

Erica S. Shenoy, MD, PhD, is an infectious diseases physician at the Massachusetts General Hospital, where she is the associate chief of the Infection Control Unit and medical director of the Regional Emerging Special Pathogens Treatment Center (RESPTC). She is an associate professor at Harvard Medical School.

Ebola: NETEC has compiled clinical guidance, preparedness resources, and educational materials related to ebola to support healthcare professionals and healthcare teams seeking reliable, evidence-informed information.
Access the resource library here.

Close Welcome Bar